Feb 05, 2018 8:00am EST Second Sight Announces Record Number of Argus II Retinal Prosthesis Systems Implants and Completes First-in-Human Orion Cortical Implant
Dec 05, 2017 9:00am EST Second Sight Announces Market Entry into Iran with First Two Implants of Argus II Retinal Prosthesis System
Nov 10, 2017 8:00am EST Ontario Health Technology Advisory Committee Recommends Public Funding for Second Sight’s Argus II Retinal Prosthesis System
Nov 08, 2017 8:00am EST Second Sight Receives FDA Expedited Access Pathway Designation for the Orion Cortical Visual Prosthesis System
Nov 02, 2017 8:05am EDT Second Sight Receives Full FDA Approval to Begin First Orion Human Clinical Study
Nov 02, 2017 8:00am EDT Second Sight Announces Final Medicare Hospital Outpatient Payment Rate for 2018 for the Argus II Retinal Prosthesis System
Oct 26, 2017 8:00am EDT Second Sight to Discuss Third Quarter 2017 Financial Results on November 2, 2017 Conference Call
Oct 19, 2017 7:00am EDT Second Sight Announces Appointments of Frank Vandeputte as Vice President and General Manager, EMEA and Asia Pacific; Gregoire Cosendai as Vice President, Clinical Affairs
Oct 17, 2017 7:00am EDT Second Sight Receives Approval from Bundesinstitut für Arzneimittel und Medizinprodukte in Germany to Begin Study to Implant and Evaluate Argus II in Better-Sighted Retinitis Pigmentosa Patients